Vascular patency after spontaneous reperfusion of artery in α2-AP+/+ mice
. | α2-AP+/+ mice . | . | . | α2-AP−/− mice . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|
. | PO . | CR . | PP . | PO . | CR . | PP . | ||||
| Day 0 | 3 | 5 | 0 | 1 | 7 | 0 | ||||
| Day 1 | 4 | 4 | 0 | 0 | 6 | 1 | ||||
| Day 2 | 1 | 7 | 0 | 0 | 1 | 7* | ||||
| Day 3 | 0 | 6 | 2 | 0 | 0* | 8* | ||||
. | α2-AP+/+ mice . | . | . | α2-AP−/− mice . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|---|
. | PO . | CR . | PP . | PO . | CR . | PP . | ||||
| Day 0 | 3 | 5 | 0 | 1 | 7 | 0 | ||||
| Day 1 | 4 | 4 | 0 | 0 | 6 | 1 | ||||
| Day 2 | 1 | 7 | 0 | 0 | 1 | 7* | ||||
| Day 3 | 0 | 6 | 2 | 0 | 0* | 8* | ||||
Vascular patency was judged to be the state at the end of the observation period on each time course. The carotid arterial or jugular vein patency was expressed as persistent occlusion (PO) when no reperfusion was observed at all; as cyclic flow reduction (CR) when the vascular reflow alternately showed stop and flows; and as persistent patency (PP) when the vascular flow was maintained until the end of the observation period.
P < .05 versus each wild-type mouse on the same time course. Data correspond to the number of vessels in each group.